Showing results (181-190 of 313) with videos related to

Sort By:
Pageof 32
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 5, 2013
Randomized open-label phase II study of decitabine in patients with low- or intermediate-risk myelodysplastic syndromesGuillermo Garcia-Manero, Elias Jabbour, Gautam Borthakur, et al.
Blood|May 3, 2002
Imatinib mesylate (STI571) therapy for Philadelphia chromosome-positive chronic myelogenous leukemia in blast phaseHagop M Kantarjian, Jorge Cortes, Susan O'Brien, et al.
Cancer|July 25, 2003
Results of decitabine (5-aza-2'deoxycytidine) therapy in 130 patients with chronic myelogenous leukemiaHagop M Kantarjian, Susan O'Brien, Jorge Cortes, et al.
Clinical Lymphoma|April 10, 2004
Management guidelines for use of alemtuzumab in B-cell chronic lymphocytic leukemiaMichael Keating, Stephen Coutré, Kanti Rai, et al.
British Journal of Haematology|February 25, 2012
Final results of the phase II study of rabbit anti-thymocyte globulin, ciclosporin, methylprednisone, and granulocyte colony-stimulating factor in patients with aplastic anaemia and myelodysplastic syndromeTapan M Kadia, Gautam Borthakur, Guillermo Garcia-Manero, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 15, 2013
Effect of NPM1 and FLT3 mutations on the outcomes of elderly patients with acute myeloid leukemia receiving standard chemotherapyNaval Daver, Theresa Liu Dumlao, Farhad Ravandi, et al.
Cancer|August 27, 2009
Phase 1 multicenter study of vincristine sulfate liposomes injection and dexamethasone in adults with relapsed or refractory acute lymphoblastic leukemiaDeborah A Thomas, Hagop M Kantarjian, Wendy Stock, et al.
Blood|August 1, 2002
The clinical significance of tumor necrosis factor-alpha plasma level in patients having chronic lymphocytic leukemiaAlessandra Ferrajoli, Michael J Keating, Taghi Manshouri, et al.
Cancer|January 19, 2012
Predicting survival of patients with hypocellular myelodysplastic syndrome: development of a disease-specific prognostic score systemWei-Gang Tong, Alfonso Quintás-Cardama, Tapan Kadia, et al.
Blood|August 9, 2011
Phase 2 study of cladribine followed by rituximab in patients with hairy cell leukemiaFarhad Ravandi, Susan O'Brien, Jeffrey Jorgensen, et al.
Pageof 32